v3.19.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 184 $ 896
Trade receivables 70 95
Other accounts receivable and prepaid expenses 57 144
Inventory 141 95
Total current assets 452 1,230
Non-current assets:    
Fixed assets, net 6 8
Severance pay fund 359 342
Total non-current assets 365 350
Total assets 817 1,580
Current liabilities:    
Trade payables 230 193
Other accounts payable and accrued expenses 321 447
Derivative Liability - Warrants 151
Total current liabilities 702 640
Non-current liabilities:    
Accrued severance pay 498 477
Convertible notes net of discount of $225 and derivative liabilities 86
Total non-current liabilities 584 477
Total liabilities 1,286 1,117
COMMITMENTS AND CONTINGENCIES
Stockholders' equity:    
Common stock of $0.001 par value - Authorized: 20,000,000 shares at March 31, 2019 and December 31, 2018; Issued and outstanding: 4,076,522 and 3,801,522 shares at March 31, 2019 and December 31, 2018, respectively 4 4
Additional paid in capital 34,740 32,993
Accumulated deficit (35,215) (32,536)
Total stockholders' equity (469) 463
Total liabilities and stockholders' equity 817 1,580
Series C Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock 2 2
Series D Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock

Source